During this reporting period, the VISSION project has made notable advancements that push the boundaries of current photonic integration technologies and design methodologies.
These achievements represent significant progress beyond the state of the art in several key areas:
Technological Advancements Beyond the State of the Art:
• Direct Micro-Transfer Printing (MTP) of functional materials such as PZT and BTO onto SiN photonic platforms was successfully demonstrated without the need for intermediate bonding layers (e.g. BCB). This innovation improves field overlap and device performance, enabling more compact and efficient electro-optic modulators.
• Electrically operated III-Nitride amplifiers were demonstrated through a complex integration process involving gain chip fabrication, underetching, and MTP. The successful realization of a Fabry-Perot laser and booster amplifier with high on-chip power validates the full process chain and sets a new benchmark for hybrid integration of active components.
• The development of a data analysis framework and integration of initial component models into the PDK significantly enhance the design flow, enabling more accurate simulations and faster iteration cycles.
• Novel device designs submitted for the SiN2 run, including high extinction ratio switches, asymmetric add-drop ring resonators, and Vernier filters, introduce new functionalities and improved performance metrics not present in earlier runs.
Expected Socio-Economic Impact
• The project’s innovations in hybrid integration and scalable fabrication processes pave the way for cost-effective, high-performance photonic systems, which are essential for next-generation applications in healthcare, communications, and sensing.
• The demonstrated integration of III-Nitride gain chips and electro-optic modulators supports the development of compact and energy-efficient light sources and signal processors, which are critical for miniaturized diagnostic tools and high-speed data transmission.
• Contributions to the OCT and Flow Cytometry demonstrators by partners such as IMEC, G&H and Sarcura highlight the project’s relevance to biomedical applications, with potential impact on early disease detection, cell analysis, and personalized medicine.
• The strengthened design infrastructure and validated fabrication processes contribute to European leadership in photonic integration, supporting industrial competitiveness and fostering innovation across sectors.